Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: results of a phase 1/2 Study (Q43209177)
Jump to navigation
Jump to search
scientific article published on 23 December 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: results of a phase 1/2 Study |
scientific article published on 23 December 2009 |
Statements
1 reference
Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: results of a phase 1/2 Study (English)
1 reference
Philip J Mease
1 reference
Nathan Wei
1 reference
Edward J Fudman
1 reference
Alan J Kivitz
1 reference
Joy Schechtman
1 reference
Robert G Trapp
1 reference
Kathryn F Hobbs
1 reference
Maria Greenwald
1 reference
Antony Hou
1 reference
Stephen A Bookbinder
1 reference
Galen E Graham
1 reference
Craig W Wiesenhutter
1 reference
Larry Willis
1 reference
Eric M Ruderman
1 reference
Joseph Z Forstot
1 reference
Michael J Maricic
1 reference
Kathryn H Dao
1 reference
Charles H Pritchard
1 reference
Darrell N Fiske
1 reference
Francis X Burch
1 reference
Pervin Anklesaria
1 reference
Alison E Heald
1 reference
23 December 2009
1 reference
1 reference
37
1 reference
4
1 reference
692-703
1 reference
Identifiers
1 reference
1 reference